Host Gene Profiling of Coxsackievirus B3 H3- and 10A1-infected Mouse Heart.
- Author:
Jae Hwan NAM
1
;
Byung Kwan LIM
;
Young Joo CHO
;
Dae Sun KIM
;
Yeun Jung KIM
;
Soo Young CHUNG
;
Young Mee JEE
;
Eun Seok JEON
Author Information
- Publication Type:Original Article
- Keywords: Coxsackievirus B3 H3; 10A1; cDNA microarray; Gene profile
- MeSH: Animals; Asparagine; Aspartic Acid; Cardiomyopathy, Dilated; Complement System Proteins; Genetic Therapy; Genome; Heart*; Mice*; Myocarditis; Oligonucleotide Array Sequence Analysis; Protein-Tyrosine Kinases; RNA; RNA, Messenger
- From:Journal of Bacteriology and Virology 2006;36(2):89-98
- CountryRepublic of Korea
- Language:Korean
- Abstract: Coxsackievirus B3 (CVB3) is a non-enveloped virus that has a single-stranded RNA genome. CVB3 induces myocarditis, and ultimately, dilated cardiomyopathy. A myocarditis variant of CVB3 (CVB3 H3) and its antibody-escape mutant (CVB3 10A1) were studied previously; H3 was found to induce myocarditis and 10A1 was found to be attenuated in infected mice. Although amino acid residue 165, located in a puff region of VP2, was found to be altered (i.e., the H3 asparagine was altered to aspartate in 10A1), the detailed mechanism of attenuation was not clearly elucidated. Here, DNA microarray technology was used to monitor changes in mRNA levels of infected mouse hearts after CVB3 H3 and 10A1 infection. This tool was used to elucidate the pathogenic mechanisms of viral infection by understanding virus-host interactions. We identified several genes, including protein tyrosine kinases, Ddr2 and Ptk2, as well as Clqb and Crry, involved in complement reactions, which may be involved in these viral processes. Thus, gene profiling can provide an opportunity to understand host immune responses to viral infection for gene therapy and may contribute to the identification of the target gene that is modified during treatment of viral myocarditis.
